Dariohealth CORP. (DRIO) — DEF 14A Filings

All DEF 14A filings from Dariohealth CORP.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (5)

DarioHealth Seeks Shareholder Approval for Director Re-election, Equity Raises — Dec 22, 2025 Risk: medium
DarioHealth Corp. (DRIO) is holding its Annual Meeting of Stockholders on January 29, 2026, to address several key proposals. Shareholders will vote on the re-e
DarioHealth Seeks Reverse Stock Split, Board Re-election — May 30, 2025 Risk: medium
DarioHealth Corp. (DRIO) filed a DEF 14A on May 30, 2025, outlining proposals for its Annual Meeting on July 23, 2025. Key proposals include the re-election of
DarioHealth Corp. Files Definitive Proxy Statement — Mar 10, 2025 Risk: low
DarioHealth Corp. filed its definitive proxy statement on March 10, 2025, for its annual meeting on April 28, 2025. The filing details information related to th
DarioHealth Files Definitive Proxy Statement — Oct 24, 2024 Risk: low
DarioHealth Corp. filed its definitive proxy statement on October 24, 2024, for its annual meeting on December 18, 2024. The company, formerly known as LabStyle
DarioHealth Corp. Announces Special Meeting of Stockholders on June 25, 2024 — May 1, 2024 Risk: medium
DarioHealth Corp. (DRIO) filed a Proxy Statement (DEF 14A) with the SEC on May 1, 2024. Special meeting of stockholders to be held on June 25, 2024, at 9:00 a.m

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX